GLP-1 Receptor Agonist Market Size, Share & Industry Analysis, By Drug (Semaglutide, Exenatide, Lixisenatide, Liraglutide, Dulaglutide, and Others), By Route of Administration (Oral and Parenteral), By Age Group (Pediatric and Adults), By Indication (Obesity, Diabetes, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI112827

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Key Indications, By Key Countries/Regions, 2024
2. Pipeline Analysis, By Key Players
3. New Product Launches, by Key Players
4. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
5. Impact of COVID-19 on the Market
Global GLP-1 Receptor Agonists Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Drug
  1. Semaglutide
  2. Exenatide
  3. Lixisenatide
  4. Liraglutide
  5. Dulaglutide
  6. Others
2. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Indication
  1. Diabetes
  2. Obesity
  3. Others
5. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
6. Market Analysis, Insights and Forecast – Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America GLP-1 Receptor Agonists Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Drug
  1. Semaglutide
  2. Exenatide
  3. Lixisenatide
  4. Liraglutide
  5. Dulaglutide
  6. Others
2. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Indication
  1. Diabetes
  2. Obesity
  3. Others
5. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
6. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe GLP-1 Receptor Agonists Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Drug
  1. Semaglutide
  2. Exenatide
  3. Lixisenatide
  4. Liraglutide
  5. Dulaglutide
  6. Others
2. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Indication
  1. Diabetes
  2. Obesity
  3. Others
5. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
6. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Germany
  2. U.K.
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific GLP-1 Receptor Agonists Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Drug
  1. Semaglutide
  2. Exenatide
  3. Lixisenatide
  4. Liraglutide
  5. Dulaglutide
  6. Others
2. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Indication
  1. Diabetes
  2. Obesity
  3. Others
5. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
6. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
  2. Japan
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America GLP-1 Receptor Agonists Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Drug
  1. Semaglutide
  2. Exenatide
  3. Lixisenatide
  4. Liraglutide
  5. Dulaglutide
  6. Others
2. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Indication
  1. Diabetes
  2. Obesity
  3. Others
5. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
6. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa GLP-1 Receptor Agonists Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Drug
  1. Semaglutide
  2. Exenatide
  3. Lixisenatide
  4. Liraglutide
  5. Dulaglutide
  6. Others
2. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Indication
  1. Diabetes
  2. Obesity
  3. Others
5. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
6. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles
  1. Eli Lilly and Company
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Sanofi
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Novo Nordisk A/S
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. AstraZeneca
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. Pfizer, Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Glenmark Pharmaceuticals Limited
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Teva Pharmaceutical Industries Ltd.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Key Indications, By Key Countries/Regions, 2024
2. Pipeline Analysis, By Key Players
3. New Product Launches, by Key Players
4. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
5. Impact of COVID-19 on the Market
Global GLP-1 Receptor Agonists Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Drug
  1. Semaglutide
  2. Exenatide
  3. Lixisenatide
  4. Liraglutide
  5. Dulaglutide
  6. Others
2. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Indication
  1. Diabetes
  2. Obesity
  3. Others
5. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
6. Market Analysis, Insights and Forecast – Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America GLP-1 Receptor Agonists Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Drug
  1. Semaglutide
  2. Exenatide
  3. Lixisenatide
  4. Liraglutide
  5. Dulaglutide
  6. Others
2. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Indication
  1. Diabetes
  2. Obesity
  3. Others
5. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
6. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe GLP-1 Receptor Agonists Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Drug
  1. Semaglutide
  2. Exenatide
  3. Lixisenatide
  4. Liraglutide
  5. Dulaglutide
  6. Others
2. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Indication
  1. Diabetes
  2. Obesity
  3. Others
5. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
6. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Germany
  2. U.K.
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific GLP-1 Receptor Agonists Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Drug
  1. Semaglutide
  2. Exenatide
  3. Lixisenatide
  4. Liraglutide
  5. Dulaglutide
  6. Others
2. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Indication
  1. Diabetes
  2. Obesity
  3. Others
5. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
6. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
  2. Japan
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America GLP-1 Receptor Agonists Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Drug
  1. Semaglutide
  2. Exenatide
  3. Lixisenatide
  4. Liraglutide
  5. Dulaglutide
  6. Others
2. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Indication
  1. Diabetes
  2. Obesity
  3. Others
5. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
6. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa GLP-1 Receptor Agonists Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Drug
  1. Semaglutide
  2. Exenatide
  3. Lixisenatide
  4. Liraglutide
  5. Dulaglutide
  6. Others
2. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Indication
  1. Diabetes
  2. Obesity
  3. Others
5. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
6. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles
  1. Eli Lilly and Company
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Sanofi
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Novo Nordisk A/S
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. AstraZeneca
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. Pfizer, Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Glenmark Pharmaceuticals Limited
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Teva Pharmaceutical Industries Ltd.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Read Less

List of Figures

Figure 1: Global GLP-1 Receptor Agonists Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032

Figure 2: Global GLP-1 Receptor Agonists Market Value Share (%), by Drug, 2024 & 2032

Figure 3: Global GLP-1 Receptor Agonists Market Value Share (%), by Route of Administration, 2024 & 2032

Figure 4: Global GLP-1 Receptor Agonists Market Value Share (%), by Age Group, 2024 & 2032

Figure 5: Global GLP-1 Receptor Agonists Market Value Share (%), by Indication, 2024 & 2032

Figure 6: Global GLP-1 Receptor Agonists Market Value Share (%), by Distribution Channel, 2024 & 2032

Figure 7: Global GLP-1 Receptor Agonists Market Value (USD billion), by Region, 2024 & 2032

Figure 8: North America GLP-1 Receptor Agonists Market Value (USD billion), by Drug, 2024 & 2032

Figure 9: North America GLP-1 Receptor Agonists Market Value Share (%), by Drug, 2024

Figure 10: North America GLP-1 Receptor Agonists Market Value (USD billion), by Route of Administration, 2024 & 2032

Figure 11: North America GLP-1 Receptor Agonists Market Value Share (%), by Route of Administration, 2024

Figure 12: North America GLP-1 Receptor Agonists Market Value (USD billion), by Age Group, 2024 & 2032

Figure 13: North America GLP-1 Receptor Agonists Market Value Share (%), by Age Group, 2024

Figure 14: North America GLP-1 Receptor Agonists Market Value (USD billion), by Indication, 2024 & 2032

Figure 15: North America GLP-1 Receptor Agonists Market Value Share (%), by Indication, 2024

Figure 16: North America GLP-1 Receptor Agonists Market Value (USD billion), by Distribution Channel, 2024 & 2032

Figure 17: North America GLP-1 Receptor Agonists Market Value Share (%), by Distribution Channel, 2024

Figure 18: North America GLP-1 Receptor Agonists Market Value (USD billion), By Country, 2024 & 2032

Figure 19: North America GLP-1 Receptor Agonists Market Value Share (%), By Country, 2024

Figure 20: Europe GLP-1 Receptor Agonists Market Value (USD billion), by Drug, 2024 & 2032

Figure 21: Europe GLP-1 Receptor Agonists Market Value Share (%), by Drug, 2024

Figure 22: Europe GLP-1 Receptor Agonists Market Value (USD billion), by Route of Administration, 2024 & 2032

Figure 23: Europe GLP-1 Receptor Agonists Market Value Share (%), by Route of Administration, 2024

Figure 24: Europe GLP-1 Receptor Agonists Market Value (USD billion), by Age Group, 2024 & 2032

Figure 25: Europe GLP-1 Receptor Agonists Market Value Share (%), by Age Group, 2024

Figure 26: Europe GLP-1 Receptor Agonists Market Value (USD billion), by Indication, 2024 & 2032

Figure 27: Europe GLP-1 Receptor Agonists Market Value Share (%), by Indication, 2024

Figure 28: Europe GLP-1 Receptor Agonists Market Value (USD billion), by Distribution Channel, 2024 & 2032

Figure 29: Europe GLP-1 Receptor Agonists Market Value Share (%), by Distribution Channel, 2024

Figure 30: Europe GLP-1 Receptor Agonists Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 31: Europe GLP-1 Receptor Agonists Market Value Share (%), By Country/ Sub-region, 2024

Figure 32: Asia Pacific GLP-1 Receptor Agonists Market Value (USD billion), by Drug, 2024 & 2032

Figure 33: Asia Pacific GLP-1 Receptor Agonists Market Value Share (%), by Drug, 2024

Figure 34: Asia Pacific GLP-1 Receptor Agonists Market Value (USD billion), by Route of Administration, 2024 & 2032

Figure 35: Asia Pacific GLP-1 Receptor Agonists Market Value Share (%), by Route of Administration, 2024

Figure 36: Asia Pacific GLP-1 Receptor Agonists Market Value (USD billion),by Age Group, 2024 & 2032

Figure 37: Asia Pacific GLP-1 Receptor Agonists Market Value Share (%), by Age Group, 2024

Figure 38: Asia Pacific GLP-1 Receptor Agonists Market Value (USD billion), by Indication, 2024 & 2032

Figure 39: Asia Pacific GLP-1 Receptor Agonists Market Value Share (%), by Indication, 2024

Figure 40: Asia Pacific GLP-1 Receptor Agonists Market Value (USD billion), by Distribution Channel, 2024 & 2032

Figure 41: Asia Pacific GLP-1 Receptor Agonists Market Value Share (%), by Distribution Channel, 2024

Figure 42: Asia Pacific GLP-1 Receptor Agonists Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 43: Asia Pacific GLP-1 Receptor Agonists Market Value Share (%), By Country/ Sub-region, 2024

Figure 44: Latin America GLP-1 Receptor Agonists Market Value (USD billion), by Drug, 2024 & 2032

Figure 45: Latin America GLP-1 Receptor Agonists Market Value Share (%), by Drug, 2024

Figure 46: Latin America GLP-1 Receptor Agonists Market Value (USD billion), by Route of Administration, 2024 & 2032

Figure 47: Latin America GLP-1 Receptor Agonists Market Value Share (%), by Route of Administration, 2024

Figure 48: Latin America GLP-1 Receptor Agonists Market Value (USD billion), by Age Group, 2024 & 2032

Figure 49: Latin America GLP-1 Receptor Agonists Market Value Share (%), by Age Group, 2024

Figure 50: Latin America GLP-1 Receptor Agonists Market Value (USD billion), by Indication, 2024 & 2032

Figure 51: Latin America GLP-1 Receptor Agonists Market Value Share (%), by Indication, 2024

Figure 52: Latin America GLP-1 Receptor Agonists Market Value (USD billion), by Distribution Channel, 2024 & 2032

Figure 53: Latin America GLP-1 Receptor Agonists Market Value Share (%), by Distribution Channel, 2024

Figure 54: Latin America GLP-1 Receptor Agonists Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 55: Latin America GLP-1 Receptor Agonists Market Value Share (%), By Country/ Sub-region, 2024

Figure 56: Middle East & Africa GLP-1 Receptor Agonists Market Value (USD billion), by Drug, 2024 & 2032

Figure 57: Middle East & Africa GLP-1 Receptor Agonists Market Value Share (%), by Drug, 2024

Figure 58: Middle East & Africa GLP-1 Receptor Agonists Market Value (USD billion), by Route of Administration, 2024 & 2032

Figure 59: Middle East & Africa GLP-1 Receptor Agonists Market Value Share (%), by Route of Administration, 2024

Figure 60: Middle East & Africa GLP-1 Receptor Agonists Market Value (USD billion), by Age Group, 2024 & 2032

Figure 61: Middle East & Africa GLP-1 Receptor Agonists Market Value Share (%), by Age Group, 2024

Figure 62: Middle East & Africa GLP-1 Receptor Agonists Market Value (USD billion), by Indication, 2024 & 2032

Figure 63: Middle East & Africa GLP-1 Receptor Agonists Market Value Share (%), by Indication, 2024

Figure 64: Middle East & Africa GLP-1 Receptor Agonists Market Value (USD billion), by Distribution Channel, 2024 & 2032

Figure 65: Middle East & Africa GLP-1 Receptor Agonists Market Value Share (%), by Distribution Channel, 2024

Figure 66: Middle East & Africa GLP-1 Receptor Agonists Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 67: Middle East & Africa GLP-1 Receptor Agonists Market Value Share (%), By Country/ Sub-region, 2024

Figure 68: Global GLP-1 Receptor Agonists Market Share (%), By Company, 2024

List of Tables

Table 1: Global GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, by Drug, 2019–2032

Table 2: Global GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, by Route of Administration, 2019–2032

Table 3: Global GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, by Age Group 2019–2032

Table 4: Global GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, by Indication, 2019–2032

Table 5: Global GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 6: Global GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, by Region, 2019-2032

Table 7: North America GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, by Drug, 2019–2032

Table 8: North America GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, by Route of Administration, 2019–2032

Table 9: North America GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, by Age Group 2019–2032

Table 10: North America GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, by Indication, 2019–2032

Table 11: North America GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 12: North America GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 13: Europe GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, by Drug, 2019–2032

Table 14: Europe GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, by Route of Administration, 2019–2032

Table 15: Europe GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, by Age Group 2019–2032

Table 16: Europe GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, by Indication, 2019–2032

Table 17: Europe GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 18: Europe GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 19: Asia Pacific GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, by Drug, 2019–2032

Table 20: Asia Pacific GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, by Route of Administration, 2019–2032

Table 21: Asia Pacific GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, by Age Group 2019–2032

Table 22: Asia Pacific GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, by Indication, 2019–2032

Table 23: Asia Pacific GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 24: Asia Pacific GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 25: Latin America GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, by Drug, 2019–2032

Table 26: Latin America GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, by Route of Administration, 2019–2032

Table 27: Latin America GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, by Age Group 2019–2032

Table 28: Latin America GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, by Indication, 2019–2032

Table 29: Latin America GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 30: Latin America GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 31: Middle East & Africa GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, by Drug, 2019–2032

Table 32: Middle East & Africa GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, by Route of Administration, 2019–2032

Table 33: Middle East & Africa GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, by Age Group 2019–2032

Table 34: Middle East & Africa GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, by Indication, 2019–2032

Table 35: Middle East & Africa GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 36: Middle East & Africa GLP-1 Receptor Agonists Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

STUDY PERIOD: 2019-2032
BASE YEAR: 2024
HISTORICAL DATA: 2019-2023
NO OF PAGES: 167

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com